Tazverik Tablet, Film Coated
Product Images NDC 72607-100

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Tazverik (NDC 72607-100). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Epizyme, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Taz02 0003 01

Chemical structure of tazemetostat hydrobromide, the active ingredient in TAZVERIK tablets. The diagram shows the molecular framework including rings and functional groups corresponding to tazemetostat with a hydrobromide moiety.*

FDA Label Image

Taz02 0003 02

TAZVERIK 200 mg film-coated tablets label showing 240 tablets per container. The label includes the active ingredient tazemetostat, the National Drug Code 72607-100-00, and manufacturer Epizyme, Inc. of Cambridge, MA. Storage instructions note not to exceed 30°C, and safety seal warnings are present. The label states Rx only and provides basic dosage reference instructions.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.